All posts by imreal

Frederick F. Buechel, Jr. M.D. Appointed Director of Robotic Assisted Knee Surgery at Lenox Hill Hospital in NYC


News Image

“I am honored for the opportunity to help shape the future of robotic surgery at Lenox Hill and look forward to working with the exceptional team of skilled surgeons,” says Dr. Frederick Buechel, Jr. M.D.

Lenox Hill Hospital, in the heart of New York City, is globally recognized for excellence in orthopedic care and has chosen Dr. Buechel as the new Director of Robotic Assisted Knee Surgery. Utilizing advanced robotic surgical technology provides Lenox Hill surgeons with unmatched precision that enables a minimally invasive approach for complex procedures with many benefits.

Frederick F. Buechel, Jr. M.D. is a board-certified orthopedic surgeon and founder of the Robotic Joint Center. In his new role, Dr. Buechel’s leadership will guide the robotic knee surgery program’s growth and development to better serve the needs of patients. Dr. Buechel is one of the world’s most skilled users of the Mako™ robotic system. Partial knee replacement is a subspecialty that he has been a pioneer in with Mako™ robotics for the past decade, and his experience and deep understanding of the robotic system’s capabilities make him a highly sought-after surgeon. Dr. Buechel will be seeing patients at two new locations, Lenox Health Greenwich Village at 200 West 13th Street, 6th Floor and Lenox Hill Hospital at 130 East 77th Street, 12th Floor in Manhattan. Dr. Buechel will also continue on in his surgical practice while taking on his new director responsibilities.

“I am honored for the opportunity to help shape the future of robotic surgery at Lenox Hill and look forward to working with the exceptional team of skilled surgeons,” says Dr. Frederick Buechel, Jr. M.D.

More about Frederick F. Buechel, Jr. M.D.:

Frederick F. Buechel, Jr., M.D. is a board-certified orthopedic surgeon who is an expert in partial and total knee joint replacements. He is the founder of the Robotic Joint Center in NYC and Taipei Postal Hospital in Taiwan. He graduated from Rutgers University Medical School and attended Drexel University in Philadelphia for his orthopedic surgery residency. Dr. Buechel then completed his fellowship training at the University of Pennsylvania. He was in private practice where he started the Mako™ robotic program in Naples, FL, in 2009. Dr. Buechel spent 5 years living in Singapore and Taiwan as a surgeon and consultant, operating and teaching surgeons in Asia and Australia how to perform Mako™ robotic knee and hip replacement. Dr. Frederick Buechel, Jr.’s practice, the Robotic Joint Center, is located at Lenox Health Greenwich Village at 200 West 13th Street, 6th Floor and Lenox Hill Hospital at 130 East 77th Street, 12th Floor in Manhattan. For more information or to schedule a consultation with Dr. Buechel, please call 212-308-3089 or visit http://www.roboticjointcenter.com.

Share article on social media or email:

Cantata Health Solutions Anchors HIMSS Webinar on Integrated Care


“When somebody receives services at an Opioid Treatment Program, a mental health clinic, and primary care agency, these organizations must be talking to each other to deliver on the promise of whole patient care,” said Tillinghast.

On July 20th, Cantata Health Solutions President and CEO, Alan Tillinghast, participated as a panelist in a webinar titled “Working Beyond the Sectors to Achieve Integrated Care.”

The HIMSS New York State Chapter hosted the event to discuss how behavioral health and physical health can work together to achieve true whole-person care.

The 90-minute conversation featured expert panelists from the public and private sectors who shared their perspectives and experiences with integrating care and what is happening on the ground. Panelist Dr. Jorge R Petit, CEO at Services for the UnderServed, said, “for me, integration is about breaking down the silos and the fragmentation that currently exists in our system, and to really think about how we create an integrated delivery service continuum that really meets the needs of individuals where they are at.”

Alan Tillinghast shared Cantata’s experience of working collaboratively with behavioral health and acute care providers to address the challenges of providing coordinated, patient-centered care.

“When you look at the integration of primary care, it’s critically important, especially in highly regulated states like Ohio, New York, and California, where program licensing models result in silos of care,” said Tillinghast. “When somebody receives services at an Opioid Treatment Program, a mental health clinic, and primary care agency, these organizations must be talking to each other to deliver on the promise of whole patient care.”

The webinar was well-received by participants and provided valuable insights into how to create successful models of care integration. Anthony M. Ferrante, President of the NYS Chapter of HIMSS, said, “we were thrilled to have Alan Tillinghast, CEO of Cantata Health Solutions, as a panelist on our webinar. His expertise in behavioral health and human services was a welcomed addition to our discussion. Alan provided invaluable insight into the current and future state of this sector.”

To watch the entire webinar, please visit the HIMSS New York State YouTube channel: https://youtu.be/1Io_ogMUjwk

About HIMSS New York State

The HIMSS New York State Chapter hosted the event to discuss how behavioral health and physical healthcare can work together on whole-person care and unravel the work being done to join these two worlds together. For more about HIMSS NYS, visit: https://www.himss.org/membership-participation/himss-new-york-state-chapter

About Alan Tillinghast

Alan Tillinghast is the CEO of Cantata Health Solutions and has worked in the healthcare technology field for more than 30 years for both vendors and providers. Prior to his joining Cantata Health Solutions, Alan was the Chief Strategy and Information Officer for Samaritan Daytop Village, one of New York’s largest health and human services providers. During his seven years at Samaritan, the organization experienced significant growth, and one of the major contributors to that growth was the organization’s extensive use of technology. Learn more about Alan Tillinghast here: https://cantatahealth.com/alan-tillinghast/

About Cantata Health Solutions

Cantata Health Solutions delivers award-winning software, purpose-built to improve the health of acute, post-acute, and behavioral health facilities and their patients. Cantata’s Revenue Cycle Management (RCM), financial management, and Electronic Health Record (EHR) software are highly configurable to meet the unique needs of each facility or healthcare system, providing staff and administrators with greater visibility into patient care across the continuum of care, improving back-office operations and clinical efficiency, ensuring predictable financial outcomes, and enhancing revenue recovery. Headquartered in Austin, Texas, their team of experts provides exceptionally attentive service and support. For more information about Cantata Health Solutions and Arize EHR, visit: https://cantatahealth.com

Share article on social media or email:

Progress and Promise, Upcoming Webinar Hosted by Xtalks


How are these new technologies enabling commercial readiness and creating meaningful opportunities to elevate the standard of care in solid tumor indications?

Natural killer (NK) cells have moved front and center as one of the most exciting therapeutic technologies in clinical development. They are considered by many experts to be a critical cell type in the fight against solid tumors.

The goal of this webinar is to provide a complete view of the progress being made in NK cell therapies alongside the promise and challenges they present as they move into the clinic.

Technology aspects: What is the lay of the land in the NK space? What improved technologies are emerging and being incorporated into the next generation of NK cell therapies? How are these new technologies enabling commercial readiness and creating meaningful opportunities to elevate the standard of care in solid tumor indications?

Manufacturing aspects: How have these novel therapeutic modalities enabled the emergence of new and scalable manufacturing platforms? What are some of the unique challenges and opportunities surrounding the manufacture of NK cells? What have we learned from the early adoption of T cell-based therapies, and how can we apply these lessons to mitigate challenges in production and ensure the delivery of life-saving treatments at commercial scale?

Clinical aspects: Why NK cells? How do they work? What is unique and compelling about their mechanism of action and why could this be advantageous in the fight against solid tumors? What is the latest thinking regarding combination therapies to drive meaningful improvements in clinical outcomes beyond the current standard of care? How might dosing strategies evolve to improve clinical outcomes and promote persistence?

Join the featured speakers to discuss NK cells, one of the fastest growing segments of the cell therapy industry.

Join Christina Coughlin, CEO, CytoImmune Therapeutics; Evren Alici, Associate Professor, Cell and Gene Therapy Group, Department of Medicine, Karolinska Institute; Volker Huppert, Chief Development Officer, Glycostem; Martin A. Giedlin, PhD, VP, Head Tech Ops, Senti Bio; Ezequiel Zylberberg, Vice President, Product Development and Planning, Akron Bio; and Robert Margolin, Vice President of Commercial, BioProducts Business, Akron Bio, for the live webinar on Thursday, August 18, 2022, at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit Natural Killer Cells: Progress and Promise.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food, and medical device communities. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends, and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

BeyondBrands Announces the Launch of Daily Practice, First-to-Market Ophthalmologist-Formulated Brand to Address Growing Need for Daily Eye Care


News Image

“So many products on the market today can undermine long-term eye health. I wanted to develop a new product category that was gentle, natural, effective, and informed by science, one that would help support one of our most vital assets: our vision,” said Dr. Brissette.

BeyondBrands announced today the launch of Daily Practice’s Eye Revive, the first product of a new innovative brand focused on ophthalmologist-formulated personal care. Eye Revive was developed by renowned New York ophthalmologist, Dr. Ashley Brissette, with leading support from BeyondBrand’s Wellbeing Director, and former CEO of Dr. Hauschka Skincare Inc., Mirran Raphaely.

“My mission has always been to help people protect their eyes and preserve their vision. However, so many products on the market today can undermine long-term eye health. I wanted to develop a new product category that was gentle, natural, effective, and informed by science, one that would help support one of our most vital assets: our vision,” said Dr. Brissette.

Dr. Brissette recognized an imminent need for a product that bridged the gap between makeup removers, skin hydrators, and eyelid cleansers while addressing the current increase in consumers complaining of eye irritation, sensitivity, and dryness.

“After 24 years in the industry, I still get excited when I’m broached with a novel idea, a drive for innovation, a synergy of compelling natural and clinical ingredients, and a mission driven aim. Ashley came to me with a bold idea and despite her being an incredible subject matter expert, she was collaborative and expansive in her thinking. We both wanted to make sure that we were breaking new ground with a concept that met high standards and broad needs. Of course, it was no small undertaking to complete this project during enormous global challenges, but we tenaciously held the vision in our hearts, worked with world class designers and scientists to bring this remarkable product into life. I’m thrilled, proud, and ready to watch it shine, as brightly as its wonderful founder does,” said Mirran Raphaely, Chair of Well-Being vertical at BeyondBrands.

On a mission to create a differentiated and effective product with the highest degree of integrity, Brissette teamed up with BeyondBrand’s Well-Being in-house industry leader, Mirran Raphaely, known for her specialized and forerunning product formulations. Together, the powerhouse team worked with an organically certified laboratory to co-create Eye Revive, a first 3-in-1 hydrator, cleanser, and make-up remover, free from the harsh chemicals or irritants commonly found in eyelid washes, makeup removers, and other surfactant-based cleansers.

“Through the many iterations of solution, Mirran was always incredible at responding to my questions and concerns, just a quick phone call or text away. I always felt she cared deeply about the brand’s mission. Mirran has a wealth of knowledge to draw from and her expertise in the natural products industry was a great fit. She helped me bring my vision to life and I am grateful for her hard work and collaboration,” added Dr. Brissette.

To meet Dr. Brissette’s rigorous standards, the product contains natural and clinically proven ingredients such as antimicrobial botanicals that help dissolve debris and makeup, marine extracts, fruit stem cells to nourish the skin, and plant stem cells for strong antioxidant and anti-inflammatory effects. The brand has additionally committed to using sustainable and circular packaging by sourcing post-consumer recycled materials. The Daily Practice team iterated more than 20 rounds of prototypes, revisions, and rigorous testing to perfect this game-changing product.

Daily Practice will amplify Dr. Brissette’s mission to help people take better care of their eyes through several charitable initiatives, including supporting global foundations that specifically fight blindness. Dr. Brissette hopes to eventually establish the Daily Practice Eye Care Foundation, which would provide funding for vision-saving surgery to underserved communities worldwide.

Daily Practice, backed by science, formulated with intention and a first-to-market offering, is poised to disrupt multiple categories. The industry expertise of the BeyondBrand’s team combined with Dr. Brissette’s medical background has positioned the company for success.

About Dr. Brissette

Dr. Ashley Brissette is a renowned ophthalmologist who has worked extensively with many patients across Manhattan, including many celebrities and VIPs. She has been voted as a Rising Star and Super Doctor multiple times by the Super Doctors listing, which publishes an annual list of top doctors in the US. Dr. B is the ophthalmologist for the New York Rangers. She is constantly tapped for expert advice and has been featured in The New York Times, Allure, New York Magazine, NBC News, USA Today and more.

About BeyondBrands

BeyondBrands, based in New York, is a full-service agency that partners with brands to level up their business from concept to on-shelf. With services spanning Go-to-Market strategy, Branding & Design, to Finance, PR, and Sales Management – BeyondBrands offers an immersive suite of strategic support that helps businesses cultivate their Passion and Purpose. BeyondBrands has proudly collaborated with some of the most disruptive brands in the Natural Products Industry. For more info visit: http://www.beyondbrands.org

Media Contact:

Margie Adelman

margie.adelman@beyondbrands.org

916-220-3500

Share article on social media or email:

Visikol to Expand Facility to Meet Growing Demand For Services


Visikol has announced today that it has expanded its Hampton, NJ facility 11,000 sq ft through the addition of lab space and office space to meet the growing demand from its clients and customers. Visikol originally spun out from Rutgers University in 2016 and over the last six years has been growing rapidly as a provider of advanced drug discovery and development services to pharmaceutical and biotech companies. Today, Visikol counts the top 20 pharmaceutical companies as clients and has been instrumental in dozens of drug discovery and development programs.

The space that Visikol has added is adjacent to its current space within the Shelbourne Building and allows Visikol to greatly grow its current footprint while keeping its team all under the same roof. Over the last two years, Visikol’s business growth has greatly accelerated as its advanced tissue imaging and advanced cell culture services have garnered widespread adoption. In particular, Visikol has developed a multiplex tissue imaging approach which has become a go-to tool for researchers developing immuno-oncology therapeutics and working to understand the immune systems role in the tumor micro-environment. These services have allowed pharmaceutical and biotech companies to address questions that they could otherwise not answer and also to accelerate their discovery and development processes.

“It has been amazing to see Visikol grow from a small closet at Rutgers into a leading contract research services company that is shaping the way that research is conducted. This additional space will allow us to better serve the needs of our clients and to continually expand the breadth and depth of our contract research services offering,” described Visikol CEO and Co-Founder Dr. Michael Johnson.

About Visikol

Visikol is a contract research services company focused on helping pharmaceutical and biotech companies accelerate their drug discovery and development programs. The company provides clients with advanced tissue imaging and advanced cell culture assay services which leverage a broad portfolio of patented and proprietary reagents, cell culture models and software. Through these services, Visikol transforms tissues into actionable insights and also helps better mimic the complex in vivo environment within in vitro assays. To this end, Visikol has the broadest portfolio of liver in vitro models in the marketplace through the acquisition of the HUREL® micro liver portfolio and also works closely with clients to develop custom models and assays that meet their cost, throughput and in vivo relevancy requirements. Additionally, Visikol manufactures and sells a suite of tissue clearing reagents and 3D immuno-labeling kits. These products allow researchers to easily and rapidly image whole tissues and 3D cell culture models in 3D instead of traditional 2D sectioning. For more information about Visikol or its services, please visit our website at visikol.com.

Share article on social media or email:

Executive Search Firm with Over 8,000 Placements Goes Through Digital Transformation to Accelerate Market Leadership


Loxo Talent Intelligence Platform

The executive search and entire professional recruiting industry has entered what will be the biggest digital transformation since the transition from desktop software to online cloud based software in the early 2000’s

This week, Loxo announced that The Mullings Group has selected Loxo’s Talent Intelligence Platform to accelerate market leadership. The Mullings Group is the Global Leader in Talent Access and Branding in the MedTech, Healthtech and Life Sciences industries including:


  • 8,000+ successful placements
  • 700+ different companies
  • 6 out of 7 continents
  • 30+ years in business
  • Consistently one of the top MRINetwork Offices within the MRINetwork of over 300 Executive Search Firms

“We have been building a business that happens to be a search firm for years. The Mullings Group has always looked at the search business in a unique way. We are the only search firm in the world that has its own media and production company, uses business and data intelligence to drive outcomes, and has multiple facilities around the globe”, said Joe Mullings Chairman & CEO of the Mullings Group Companies.

“We continue to expand our footprint. Our annual per desk average billing is over $1 million per year which is nearly 5x the industry average. We needed an ATS / CRM partner that understood present-day search and talent access but also positioned itself for the evolving world of work and after evaluating nearly a dozen platforms, Loxo was our choice.”

“The executive search and entire professional recruiting industry has entered what will be the biggest digital transformation since the transition from desktop software to online cloud based software in the early 2000’s,” said Matt Chambers, Founder and CEO of Loxo.

  • Technology is playing an ever increasing role in how executive search and professional recruiting consultants accomplish their job responsibilities in the most efficient way possible.
  • The Mullings Group previously used an applicant tracking system called PCRecruiter for many years, before building their own proprietary database.

“When The Mullings Group made their decision to select Loxo after evaluating nearly a dozen platforms, I have to admit it was a special moment because we knew how much time and resources they invested into evaluating the very best ATS/CRMs in the market and how high their bar is in everything they do. They invested hundreds of hours into researching, sitting through product demos, doing back channel references across their networks and eventually doing extensive trials with the top finalists. We couldn’t be more excited to help contribute towards their continued success in the years to come,” said Matt Chambers.

About Joe Mullings:

Joe is the Chairman & CEO of The Mullings Group Companies, including TMG Search, Dragonfly Stories & TMG360 Media. The search firm is responsible for more than 8,000 successful searches in the medtech / healthtech / life sciences industry with clients ranging from multi-billion-dollar companies to emerging tech startups worldwide. Dragonfly Stories, which produces attention & awareness campaigns for companies globally, is the media production company behind the 7x Telly Award-Winning video docuseries, “TrueFuture,” of which Joe is the host. TMG360 Media utilizes the power of media and outreach in medtech / healthtech to move businesses and health forward. In 2020, Joe was appointed Chief Vision Officer for MRINetwork, Inc. MRINetwork includes over 300 search firms around the world, where Joe guides the digital transformation of the organization bringing video storytelling strategies and techniques for talent access, which he innovated at The Mullings Group.

About The Mullings Group:

In 1992, The Mullings Group decided to go “all in” on medical device because people were not only living longer but wanting to live healthier and we know technology would always seek a higher ground. Since then, we have successfully completed more than 8,000 searches in the medtech / healthtech / life sciences industry with over 700 companies globally.

As the only search firm in the world with a full media and marketing arm in our organization, we understand how critical it is to tell stories at scale to support attention & awareness, M&A, Recruiting & Talent Access for emerging technology companies. Our 7-time Telly Award-Winning media and production company, Dragonfly Stories, has created content for some of the most successful medtech firms in the world.

Being the most recognized hiring brand in the medtech space is important to consider as you bring your hiring brand to market. We have established ourselves as the Subject Matter Experts in developing companies and careers. With over 100,000 sets of eyes on us every day on career platforms like LinkedIn, where careers are built, we are the trusted partner in the industry.

About Loxo

Loxo is the #1 Talent Intelligence Platform and global leader in recruiting software. Loxo is a horizontally integrated suite of data-driven and AI-powered products designed to manage the full recruitment life cycle through a single system-of-record software platform. The platform includes a best-in-class ATS, an AI-driven recruiting CRM, talent graph of over 750 million people, with contact information including verified mobile phone, personal and work emails. The instant AI sourcing, ranking and matching, and multi-channel outbound recruiting solution makes identifying, engaging and hiring the very best possible talent easier than ever before. More than 4,300 Executive Search, RPO, professional recruitment and talent acquisition teams across the globe are using Loxo to become hiring machines. Learn more at https://loxo.co/

Share article on social media or email:

Medianova is Proud to Announce the Launch of a New PoP in Cairo, Egypt.


CDN Infrastructure Map in MENA

“Medianova’s vision is to become the fastest and major CDN provider in Europe, Middle East and Africa. In a multi-cdn world, Medianova will be a key player to deliver content and edge services in the region”

Continuing to grow rapidly in the Middle East & North Africa region, Medianova has announced a new PoP in Egypt, further strengthening its infrastructure by launching its 12th PoP in MENA; 6 in Saudi Arabia, 2 in UAE, 1 in Qatar and 2 in Kuwait. Medianova’s new investment in Egypt providing 200 GB capacity will increase performance and security of many industries such as e-commerce, OTT and gaming by providing the fastest and best performing CDN service in the area.

Medianova’s CEO Serkan Sevim said; “Medianova’s vision is to become the fastest and major CDN provider in Europe, Middle East and Africa. We are proud to launch our presence in Egypt to help global companies serving North Africa and Egyptian digital companies. In a multi-cdn world, Medianova will be a key player to deliver content and edge services in the region”

About Medianova

Medianova provides global CDN solutions and cloud platforms. Gartner-mentioned company has deep experience in streaming, encoding, caching, microcaching, hybrid CDN, S3-like cloud storage, API, and website acceleration. With its footprint of 50+ PoPs in 22 countries and 100% SSD-powered Anycast network, Medianova is one of the fastest HTTPS secure CDNs in Europe and in the Middle East based on Cedexis.

http://www.medianova.com

Share article on social media or email:

Slone Partners Places George Cardoza as Chief Executive Officer at AccuraGen


Slone Partners

“George Cardoza is a highly accomplished financial and operations leader with a solid track record of success in the life sciences industry,” said Slone Partners President Tara Kochis.

Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of George Cardoza as Chief Executive Officer (CEO) and as member of the Board of Directors at AccuraGen, a biotechnology research company that has pioneered the development of liquid biopsy technology to facilitate more personalized cancer treatment.

Cardoza joins AccuraGen following a 12-year tenure at NeoGenomics Laboratories where he served as Chief Financial Officer (CFO) from 2009-2018; President, Pharma Services Division from 2018-2021; and as President and Chief Operating Officer (COO), Lab Operations from 2021-2022. Earlier in his career Cardoza served as CFO at Protocol Integrated Direct Marketing; CFO of Protocol Marketing; and Controller, Central Region at Quest Diagnostics.

“George Cardoza is a highly accomplished financial and operations leader with a solid track record of success in the life sciences industry,” said Slone Partners President Tara Kochis. “He is smart, passionate, and visionary with impeccable credentials, and will be a terrific addition to the AccuraGen leadership team.”

“We are thrilled to have George join AccuraGen as CEO and lead us into the next phase for the company. We also are grateful to Kang for his contribution as CEO and look forward to continuing to work closely with him in China and at the Board,” said Dan Zabrowski, Board Member of AccuraGen and Venture Partner, Decheng Capital.

“I’m honored and excited to be the new CEO of AccuraGen,” said Cardoza. “I’m looking forward to working with the teams in both United States and China. I’ve been extremely impressed by the teams and the technology that they have developed as the Company is a hidden gem. AccuraGen’s platform can be used by laboratories around the world to improve patient care.”

Cardoza earned his Bachelor’s Degree in Finance and Accounting from Syracuse University and his M.B.A. in Management from Michigan State University Eli Broad College of Business.

ABOUT SLONE PARTNERS

Slone Partners delivers the leaders who build amazing and diverse life sciences and healthcare organizations – People Are Our Science®. Founded in 2000, Slone Partners specializes in delivering world-class C-suite leadership, executive, and upper management talent to the most promising and established biotech, diagnostics, research tools, healthcare, precision medicine, medical device, and laboratory services companies. With national and global clients, Slone Partners uniquely and precisely provides an array of executive search and advisory services, including diversity, equity, and inclusion strategy, to innovative life sciences and healthcare companies. To learn more about Slone Partners’ value proposition and processes, visit http://www.slonepartners.com or call 888.784.3422.

ABOUT ACCURAGEN

AccuraGen aims to revolutionize cancer management through technology innovation in molecular testing. AccuraGen focuses on the analysis of highly fragmented circulating nucleic acid in blood and has developed proprietary technologies enabling superior performance in the analysis of genomic, epigenetic, and RNA changes. AccuraGen is headquartered in San Jose, California, USA with CAP-accredited facility in Shanghai, China. To learn more about the company, visit https://www.accuragen.com/.

Share article on social media or email:

Unitek Learning Names VP of Nursing, Regulation, and Program Expansion


Unitek Learning is the parent company of several distinguished learning institutions: Unitek College, Unitek EMT, Eagle Gate College, Provo College, and Brookline College.

The addition of Dr. García marks another step forward as we continue to expand our programs, enabling us to partner with boards of nursing, healthcare organizations, and our local communities to help solve nursing workforce shortages.

Unitek Learning is thrilled to announce a new addition to their leadership team. In June, Rick García, Ph.D., RN, CCM, FAAOHN, FNYAM, FAADN, joined Unitek as the Vice President of Nursing, Regulation, and Program Expansion.

“The addition of Dr. García marks another step forward as we continue to expand our programs, enabling us to partner with boards of nursing, healthcare organizations, and our local communities to help solve nursing workforce shortages,” said Dr. Abdel Yosef, Provost and Chief Academic Officer at Unitek Learning. “Dr. García will focus on nursing regulatory approvals and expansion initiatives. We are so proud of our outstanding leadership members who are incredibly dedicated, working around the clock to support the talented faculty and staff across all Unitek campuses.”

Dr. García has nearly three decades of active clinical nursing practice across a multitude of administrative and clinical settings. He served as the Director of Nursing Education for the American Association of Colleges of Nursing, where he led the collaboration and development of position statements to include: 2022: Pathways to Excellence, 2021 The Essentials, 2019 AACN’s Vision for Academic Nursing, and the 2018 Defining Scholarship for Academic Nursing. He has developed conference and webinar content and initiatives to help nursing faculty transition to competency-based education. Previously, he served as the Executive Director of the Florida Board of Nursing, focusing on the regulation, licensure, and discipline of nurses and nursing programs.

Dr. García also serves as Chair of the Education Committee and a Registered Nurse Member of the District of Columbia Board of Nursing. In addition, Dr. García’s professional contributions have been recognized by the Florida State Occupational Health Nurses Association (FSAOHN) with the awarding of the accolade of Nurse of the Year in 2016 and an Honorary Lifetime Membership.

“We are so thrilled to welcome Dr. García to Unitek,” said Janis Paulson, Chief Executive Officer at Unitek Learning. “In 2022, it’s crucial that we support workforce development and focus on the future of the nursing profession. As we continue to grow, adapt, and innovate, we can better serve communities across the United States.”

Unitek Learning is the parent company of several distinguished learning institutions: Unitek College, Unitek EMT, Eagle Gate College, Provo College, and Brookline College. Unitek programs teach the clinical practices and theory used in the field today. Equipped with a multitude of sought-after skills, Unitek graduates are prepared to excel in many of the fastest-growing careers in healthcare and nursing.

Share article on social media or email:

Kayal Pain & Spine Center Approved As 2022 NJ Top Docs Practice


News Image

Kayal Pain & Spine Center has the most sophisticated diagnostic tools to pinpoint the source of your back pain or spinal problem and the most up-to-date treatments and therapies to manage and conquer whatever ails you. The compassionate team at Kayal Pain & Spine Center will be there for you every step of the way as they know most people feel anxious or scared when surgery is looming. But it’s just as important for you to know that you will not find better spine doctors in Bergen County or beyond.

Robert A. Kayal, MD, FAAOS, FAAHKS, founder of Kayal Pain & Spine Center, has assembled an elite team of world-class surgeons and specialists with superior training and impeccable skills. Team member Steve M. Aydin, DO has been reviewed and approved NJ Top Docs.

Dr. Aydin is Chief of Physical Medicine & Rehabilitation and Interventional Pain Management at Kayal Orthopaedic Center. He has taken an avid interest in interventional pain management and regenerative medicine and has published, lectured and taught on these topics on the national and international level.

Dr. Paul Bagi also practices at Kayal Pain and Spine Center and is an up and coming Top Doctor.

To learn more about the NJ Top Docs at Kayal Pain & Spine Center, please visit: https://njtopdocs.com/nj-doctors/kayalpainspine/

About Us

NJ Top Docs is a comprehensive, trusted and exclusive healthcare resource featuring reviewed and approved Top Doctors and Dentists in New Jersey online in an easy to use format. NJ Top Docs only reviews and approves providers based on merit after they have been extensively vetted.

NJ Top Docs is a division of USA Top Docs which allows patients to meet providers online before making their appointment.

For more information, please click here to contact us or visit http://www.NJTopDocs.com.

You can also follow us on Facebook, Twitter, & Instagram.

Share article on social media or email: